A Phase I Trial of PI3Kαδ Inhibitor Copanlisib in Combination with Nivolumab in Patients with Richter's Transformation (RT) or Transformed Non-Hodgkin Lymphoma (tNHL)

被引：4

作者：

Shouse, Geoffrey ^{[1
]}

Siddiqi, Tanya ^{[2
]}

Popplewell, Leslie L. ^{[3
]}

Muir, Alexandra ^{[2
]}

Melgar, Ivana ^{[4
]}

Gonzales, Brandy ^{[4
]}

Orand, Kirsten ^{[2
]}

Puverel, Sandrine ^{[4
]}

Wang, Lili ^{[5
]}

Kittai, Adam S. ^{[6
]}

Chen, Lu ^{[7
]}

Davids, Matthew S. ^{[8
]}

Danilov, Alexey V. ^{[1
]}

机构：

[1] City Hope Natl Med Ctr, Comprehens Canc Ctr, Duarte, CA USA

[2] City Hope Natl Med Ctr, Natl Med Ctr, Duarte, CA USA

[3] City Hope Natl Med Ctr, Dept Hematol, Natl Med Ctr, HCT, Duarte, CA USA

[4] City Hope Natl Med Ctr, Duarte, CA USA

[5] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA

[6] Ohio State Univ, Div Hematol, Columbus, OH USA

[7] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA

[8] Dana farber Boston Childrens Canc & Blood Disorde, Dept Med Oncol, Boston, MA USA

来源：

关键词：

D O I：

10.1182/blood-2021-149320

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3558

引用

页数：4